JockoJohnson
Golden Member
- May 20, 2009
- 1,417
- 60
- 91
Uhh since when? 1960?
Well we spend a lot on research, but as far as introducing ground breaking cures and technology I'll have to disagree.
As far as the OPs concern, that is the case for all forms of insurance. That is the exact purpose of it. Why? It's a social net so that the relatively few that need it aren't without. Some will argue that it is not needed at all, but that is for another debate.
The problem with healthcare costs in America is that everything costs way to damn much. From simple things such as a regular checkup or blood work to more exotic procedures. It all costs way to damn much here. I have some ideas to help solve that problem, but they will never be acted upon.
Again, the relatively few using the most of the current amount of money for a social system has always been the case. Indeed, it is better that the fewer using a social system the better. That is not to say that a social system is not needed at all, but that the relative need for it be as low as possible.
Disagree all you want, but you'll be wrong. Heres a link to wiki, and if you care to, click the footnotes: http://en.wikipedia.org/wiki/Health_care
In terms of pharmaceutical R&D spending, Europe spends a little less that the United States (22.50bn compared to 27.05bn in 2006) and there is less growth in European R&D spending.[6][7] Pharmaceuticals and other medical devices are the leading high technology exports of Europe and the United States. [7][8] However, the United States dominates the biopharmaceutical field, accounting for the three quarters of the worlds biotechnology revenues and 80% of world R&D spending in biotechnology.
Theres also a link here with external footnote links: http://www.futurepundit.com/archives/003794.html
But the American health care system may be performing better than it seems at first glance. When it comes to medical innovation, the United States is the world leader. In the last 10 years, for instance, 12 Nobel Prizes in medicine have gone to American-born scientists working in the United States, 3 have gone to foreign-born scientists working in the United States, and just 7 have gone to researchers outside the country.
In real terms, spending on American biomedical research has doubled since 1994. By 2003, spending was up to $94.3 billion (there is no comparable number for Europe), with 57 percent of that coming from private industry. The National Institutes of Healths current annual research budget is $28 billion, All European Union governments, in contrast, spent $3.7 billion in 2000, and since that time, Europe has not narrowed the research and development gap. America spends more on research and development over all and on drugs in particular, even though the United States has a smaller population than the core European Union countries. From 1989 to 2002, four times as much money was invested in private biotechnology companies in America than in Europe.
So who's eating their HumblePie now?